Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle

Neuromuscular Disorders

Volumn 6, Issue 3, 1996, Pages 177-185

  Juzans, Pascal ^a   Comella, Joan X ^b   Molgo, Jordi ^a   Faille, Lucette ^a   Angaut Petit, Denise ^a  

^a CNRS   (France)

^b Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

Author keywords

Botulinum type A toxin; Motor nerve terminals; Muscle paralysis and recovery; Neuromuscular junction; Terminal sprouting

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; CHOLINESTERASE; NEUROTRANSMITTER; SYNAPTOPHYSIN; SYNAPTOTAGMIN;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; IMMUNOCHEMISTRY; MORPHOLOGY; MOUSE; MUSCLE; NERVE ENDING; NERVE GROWTH; NEUROMUSCULAR TRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SILVER STAINING; TIME;

EID: 0029898538     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-8966(96)00041-7     Document Type: Article

References (36)

1. Habermann E, Dreyer F. Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr Top Microbiol Immimol 1986; 129: 93-179.
2. Molgó J, Comella J X, Angaut-Petit D, et al. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions. J Physiol (Paris) 1990; 84: 152-166.
3. Niemann H, Blasi J, Jahn R. Clostridial neurotoxins: new tools for dissecting exocytosis. Trends in Cell Biol 1994; 4: 179-185.
4. Montecucco C, Schiavo, G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 1994; 13: 1-8.
5. Poulain B, Molgó J, Thesleff S. Quantal neurotransmitter release and the clostridial neurotoxins' targets. Curr Top Microbiol Immunol 1995; 195: 243-255.
6. Duchen L W, Strich S J. The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Quart J Exp Physiol 1968; 53: 84-89.
7. Pestronk A, Drachman D B. Motor nerve outgrowth: reduced capacity for sprouting in the terminals of longer axons. Brain Res 1988; 463: 218-222.
8. Angaut-Petit, D, Molgó J, Comella J X, Faille L, Tabti N. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 1990; 37: 799-808.
9. Scott A B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044-1049.
10. Schantz E J, Johnson E A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992; 56: 80-99.
11. Jankovic J, Brin M F. Therapeutic uses of botulinum toxin. New Engl J Med 1991; 324: 1186-1194.
12. Holds J B, Alderson K, Fogg S G, Anderson R L. Motor nerve sprouting in human obicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 1990; 31: 964-967.
13. Tonge D A. Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse. J Physiol 1974 241: 127-139.
14. Jahn R, Südhof T C. Synaptic vesicles and exocytosis. Annu Rev Neurosci 1994; 17: 219-246.
15. Molgó J, Siegel L S, Tabti N, Thesleff S. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D. J Physiol (London) 1989; 411: 195-205.
16. Jahn, R, Schiebler W, Ouimet C, Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 1985; 82: 4137-4141.
17. Navone F, Jahn R, Di Gioia G, Stukenbrok H, Greengard P, De Camilli P. Protein p38: an integral protein specific for small vesicles of neurons and neuroendocrine cells. J Cell Biol 1986; 103: 2511-2527.
18. Angaut-Petit D, Juzans P, Molgó J, Faille L, Seagar M J, Shoji-Kasai Y, Takahashi M. Mouse motor nerve terminal immunoreactivity to synaptotagmin II during sustained quantal transmitter release. Brain Res 1995; 681: 213-217.
19. Valtorta F, Jahn R, Fesce R, Greengard P, Ceccarelli B. Synaptophysin (p38) at the frog neuromuscular junction: its incorporation into the axolemma and recycling after intense quantal secretion. J Cell Biol 1988; 107: 2717-2727.
20. Osen-Sand A, Catsicas M, Staple J K, et al. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 1993; 364: 445-448.
21. Bonner P H, Friedli A F, Baker R S. Botulinum A toxin stimulates branching in nerve-muscle cocultures. Dev Brain Res 1994; 79: 39-46.
22. Pestronk A, Drachman D B. Motor nerve sprouting and acetylcholine receptors. Science 1978; 199: 1223-1225.
23. Gundersen K. Spontaneous activity at long-term silenced synapses in rat muscle. J Physiol (London) 1990; 430: 399-418.
24. Comella J X, Molgó J, Faille L. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type D toxin and the functional recovery of paralysed neuromuscular junctions. Neurosci Lett 1993; 153: 61-64.
25. Brown M C, Holland R L, Hopkins W G. Motor nerve sprouting. Annu Rev Neurosci 1981; 4: 17-42.
26. Wernig A, Herrera A A. Sprouting and remodelling at the nerve-muscle junction. Prog Neurobiol 1986; 27: 251-291.
27. Angaut-Petit D, Mallart A, Faille L. Role of denervated sheaths and endplates in muscle reinnervation by collateral sprouting in the mouse. Biol Cell 1982; 46: 277-290.
28. Connold A L, Vrbová G. Neuromuscular contacts of expanded motor units in rat soleus muscle are rescued by leupeptin. Neuroscience 1994; 63: 327-338.
29. Tsujimoto T, Kuno M. Calcitonin gene-related peptide prevents disuse-induced sprouting of rat motor nerve terminals. J Neurosci 1988; 8: 3951-3957.
30. Ishii D N. Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis. Proc Natl Acad Sci USA 1989; 86: 2898-2902.
31. Caroni P, Schneider C, Kiefer M C, Zapf J. Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell Biol 1994; 125: 893-902.
32. Sala C, Andreose J S, Fumagalli G, Lomo T. Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions. J Neurosci 1995; 15: 520-528.
33. Hassan S M, Jennekens, F G I, Wieneke G, Veldman H. Calcitonin gene-related peptide like immunoreactivity, in botulinum toxin-paralysed rat muscles. Neuromusc Disord 1994; 4: 489-496.
34. Deschenne M R, Maresh C M, Crivello J F, Armstrong L E, Kraemer W J, Covault J. The effect of exercise training of different intensities on neuromuscular junction morphology. J Neurocytol 1993; 22: 603-615.
35. Funakoshi H, Belluardo N, Arenas E, et al. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 1995; 268: 1495-1499.
36. Duchen L W. An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 1971; 14: 47-60.